Bessemer Group’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Hold |
286,988
| – | – | ﹤0.01% | 479 |
|
|
2025
Q1 | $827K | Hold |
286,988
| – | – | ﹤0.01% | 763 |
|
|
2024
Q4 | $1.35M | Hold |
286,988
| – | – | ﹤0.01% | 711 |
|
|
2024
Q3 | $1.03M | Hold |
286,988
| – | – | ﹤0.01% | 771 |
|
|
2024
Q2 | $1.78M | Hold |
286,988
| – | – | ﹤0.01% | 531 |
|
|
2024
Q1 | $2.71M | Hold |
286,988
| – | – | ﹤0.01% | 474 |
|
|
2023
Q4 | $1.94M | Hold |
286,988
| – | – | ﹤0.01% | 486 |
|
|
2023
Q3 | $1.28M | Hold |
286,988
| – | – | ﹤0.01% | 567 |
|
|
2023
Q2 | $947K | Hold |
286,988
| – | – | ﹤0.01% | 658 |
|
|
2023
Q1 | $818K | Hold |
286,988
| – | – | ﹤0.01% | 624 |
|
|
2022
Q4 | $2.09M | Buy |
286,988
+1,274
| +0.4% | +$9.27K | 0.01% | 441 |
|
|
2022
Q3 | $2.31M | Hold |
285,714
| – | – | 0.01% | 419 |
|
|
2022
Q2 | $1.4M | Hold |
285,714
| – | – | ﹤0.01% | 512 |
|
|
2022
Q1 | $6.76M | Sell |
285,714
-23,707
| -8% | -$561K | 0.01% | 238 |
|
|
2021
Q4 | $5.47M | Sell |
309,421
-1,197
| -0.4% | -$21.2K | 0.01% | 240 |
|
|
2021
Q3 | $8.76M | Buy |
310,618
+24,904
| +9% | +$702K | 0.02% | 224 |
|
|
2021
Q2 | $2.99M | Hold |
285,714
| – | – | 0.01% | 283 |
|
|
2021
Q1 | $3.37M | Hold |
285,714
| – | – | 0.01% | 277 |
|
|
2020
Q4 | $3.35M | Hold |
285,714
| – | – | 0.01% | 265 |
|
|
2020
Q3 | $2.27M | Hold |
285,714
| – | – | 0.01% | 314 |
|
|
2020
Q2 | $5.23M | Hold |
285,714
| – | – | 0.02% | 286 |
|
|
2020
Q1 | $3.41M | Hold |
285,714
| – | – | 0.01% | 334 |
|
|
2019
Q4 | $4.75M | Hold |
285,714
| – | – | 0.02% | 348 |
|
|
2019
Q3 | $1.9M | Buy |
+285,714
| New | +$1.9M | 0.01% | 531 |
|